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routine
surveillance
In 1987,93 Escherichia
coli0157:H7isolateswerecollected
during
were
andplasmidprofiles
inthestateofWashington.
Toxingenotypes
forthispathogen
fromwhomthese
withtheclinicalsequelaeofillnessin88 ofthe93 patients
correlated
isowereobserved
strains
wereisolated.Thirteen
amongthe88 tested
plasmidpatterns
forShiga-like
accounted
for82(7oof theisolates.Geneticprobing
lates;fourpatterns
ofbothgenesin67 (76^0),SLT I alone
thepresence
toxins
(SLT) I andII demonstrated
orthromuremic
inthree
syndrome
(3^0),andSLT II alonein 18(20^0).Thehemolytic
inseven(39^o)of 18patients
infected
with
boticthrombocytopenic
developed
purpura
inonlyfour(6^0)
occurred
isolates
having
onlytheSLTII gene,whilethesecomplications
of 70 patients
infected
withisolateshavingtheothertwogenotypes
risk,6.8;
(relative
showsthatE. coli0157:H7isolatessyste95^0confidence
interval,
1.9,26.4).Thisstudy
timeperiodexhibit
froma singlegeographic
collected
regionovera defined
matically
inplasmid
andtoxingenotype
andthatthetoxingenotype
content
considerable
diversity
theriskofdeveloping
oftheinfecting
strain
microangiopathic
sequelae.
mayinfluence
tributeto thehighlyvariablerateof complications
EntericinfectionwithEscherichiacoli 0157:H7, a
as
a
first
[2, 5], but strainsof E. coli 0157:H7 mayalso vary
recognized
organism
cytotoxin-producing
humanpathogenin 1982 [1], leads to a spectrum in theirabilityto produceHUS and TTP. Although
of illnessesthat can includenonbloodydiarrhea, E. coli 0157:H7 isolatesfrommultiplegeographic
timeperiodsappearto be highly
uremicsyndrome areasand different
colitis,thehemolytic
hemorrhagic
[8],theyvaryin plasmidcontent[9] and
thrombocytopenic
purpura interrelated
(HUS), and thrombotic
distincttoxinsknownas
(TTP) [2]. The incidenceof HUS and TTP was re- producetwoantigenically
Shiga-liketoxins(SLT) I and II, also termedveroportedto be low in two seriesof sporadiccases of
E. coli infections[3, 4], but in outbreaks toxinsI and II [10].
cytotoxic
betweenstrainvariabilTo assesstherelationship
theproportionof patientsdevelopingthesecompliand clinicalillness,weperformed
cationshas rangedfromnone [1] to 53^0 [5]. The
itycharacteristics
reasonsforthisvaryingcomplicationrateare unplasmidanalysisand geneticprobingforSLT genoto theWashington
clear.E. coli 0157:H7-relatedHUS and TTP are
typeon patientisolatesreferred
StatePublic Health Laboratoryas partof thefirst
morecommonat theextremesof age [2], but even
in reportedoutbreaksinvolving
year of notifiabledisease surveillanceof E. coli
elderlypatientsthe
0157:H7 infections
ratesof HUS and TTP haverangedfrom3^0 [6] to
[11].Because clinicalstatuswas
22^0 [7] of cases. Factorssuchas hostresponse,inknown,wecouldcompareisolatesfrompatientswith
and withoutHUS and TTP.
and possiblyothersmayconoculumsize,treatment,
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Methods
During 1987, bacterial isolates referredto the
WashingtonState Public Health Laboratoryfrom
as E. coli0157:
93 different
patientswereconfirmed
isolateswereplatedon MacConH7. All submitted
culturemedium[12],and sorbitol-negkey-sorbitol
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ativeE. colicolonieswereserotyped
usingtubeagH7 antigens.
for
both
the
0157
and
glutination
Isolatesconfirmed
as E. coli0157:H7werestored
infusion
at roomtemperature
on brain-heart
agar
slants.
in
Clinicalandepidemiologic
datawerecollected
a standardized
manner
fromcase-patients
(ortheir
withconfirmed
E. coli0157:H7infections
parents)
coandfrom
their
Hemorrhagic
attending
physician.
litiswasdefinedas acutegrossly
bloodyor bloodstoolsovera
streaked
diarrhea
(^3 looseorwatery
24-hperiod).PatientsdiagnosedwitheitherHUS
orTTP hadthetriadofacutemicroangiopathic
anemia (hematocrit
OOVo) withevidenceof redcell
a platelet
ona peripheral
count
smear,
fragmentation
of^50,0007mm3
^.0 mg/dl.
creatinine
, andserum
Plasmidswereanalyzedbythemethodof Portin"L"
thatisolatesweregrown
noyetal. [13],except
broth
ofbrain-heart
infusion
broth
instead
andthere
inplasmid
wereminor
modifications
methods.
drying
SLTI andSLTII probesconsisting
ofradiolabeled
internal
oftherespective
toxinstructural
fragments
were
to
used determine
SLT genotype
genes
[14].
isolatesgrown
onnutrient
Sampleandcontrol
agar
weretransferred
toWhatman
541paper,steamdenaanddriedas described
indetail
tured,neutralized,
elsewhere
[15].IsolateswereprobedbyP. I. T, who
wasblindedto theclinicaldatathataccompanied
thestrains.
Calculation
ofrelative
risksandconfidence
intervalswasperformed
the
described
methods
using
by
Thomas[16].Stratified
theevaluanalysis,
including
ationofinteraction
between
wasdoneby
variables,
thesamemethods.
Results

inall
midof ~98 kilobasepairs(kbp)waspresent
88 isolates(table1). In 13(ISVo)isolates,no other
whiletheremaining
75had
weredetected,
plasmids
1-4additional
bands.
These
bands
ranged
plasmid
from2 kbpto 87 kbp.A totalof 13plasmidpatternswereobserved,althoughfourpatterns
accounted
for82^0oftheisolates.
Table1liststheplasmidprofiles
of isolatesfrompatientsby disease
No individual
of
category.
plasmidorcombination
associatedwithcasesof
plasmidswassignificantly
HUS or TTP.
Toxingenotype
analysis. Eachofthe88E. coli
0157:H7isolates
tested
thegenesequence
contained
ofat leastoneoftheShiga-like
toxins.Of theiso18(20^?) hadonly
lates,3 hadonlySLT I present,
SLT II, andtherest(67,76*70)
hadbothSLT I and
SLT II sequences.
Theagedistribution
ofpatients
bySLTgenotype
is shownin figure1. Whilethemeanand median
withisolatescontaining
thethree
agesof patients
with
were
genotypes similar,
patients onlytheSLT
II sequenceweremorelikelyto be at theextremes
ofage.Fourteen
whoseisolates
(78^0)of18patients
hadtheSLT II sequencealonewere^0 yor^0 y
oldcompared
with32(46^0)ofthe70patients
whose
isolates
hadtheother
twogenotypes
(rateratio[RR],
interval
1.7;95^0 confidence
[CI], 1.1,2.2).
IsolatesofE. coli0157:H7containing
solelythe
SLT II genecausedillnessthatprogressed
to HUS

Table 1. Plasmidprofiles
of88 Escherichia
coli0157:H7
isolatesfrompatients
inthestateofWashington,
byclinical
outcome,1987.
Plasmid
profile(kbp)

HUS-TTP

Non-HUS-TTP

Total
(%)

4
33
37 (42)
(95^0) of the 93 isolatesof E. coli 98,3
Eighty-eight
1
14
15 (17)
98,6
0157:H7wereavailablefortesting;
theremaining
5
98
4
9
13 (15)
hadbecomenonviable
Thespectrum 98,60,3
during
storage.
1
6
7 (8)
ofillnessrepresented
non- 98,6,3
0
3
3 (3)
bytheseisolatesincluded
0
3
3 (3)
in3 (3^0)patients,
co- 98,33,6,2
bloodydiarrhea
hemorrhagic
0
2
2 (2)
98,33,6
litis(HC) in 74 (84^o),HC followed
in
HUS
9
by
1
1
2 (2)
98,60
The 5
(l(Wo),andHC followed
byTTP in2 (2*7o).
0
2
2 (2)
98,8,6,5
nonviable
isolateswerefrompatients
withuncom- 98,33,3
0
1
1 (1)
0
1
1 (1)
plicatedHC. Allisolatescamefromsporadiccases 98,45
0
1
1 (1)
ofillness,
exceptforfourpairsofisolatesthatcame 98,87,3
0
1
1 (1)
98,87,11,3
frommembers
of thesamehousehold.In eachof
11
77
thesepairstheisolateshadsimilar
88(100)
plasmidprofiles Total
and toxingenotypes.
=
=
NOTE, kbp kilobase
uremic
pairs,HUS hemolytic
synPlasmidprofiles. On plasmidanalysis,
a plas- drome,TTP = thrombotic
thrombocytopenic
purpura.
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A. SLT I and SLT I and II Isolates

d]
Bi

HUS/TTP
Non-HUS/TTP

of paFigure1. Age distribution
tientswithEscherichia
coli 0157:H7
infections
by (A) Shiga-liketoxins
(SLT) I and I and II and (B) SLT II
uremicsynonly.HUS = hemolytic
TTP = thrombotic
thrombodrome,
cytopenic
purpura.

Age Group

B. SLT II only isolates
Q
HI

HUS/TTP
Non-HUS/TTP

Age Group

or TTP in 7 (39^0) of 18patients.In contrast,only
4 (6^0) of the70 isolateswiththeothergenotypes
werefrompatientswiththesecomplications(RR,
6.8; CI, 1.9,26.4). Whentheanalysiswas restricted
to patientsat the age extremesindicatedabove
thegroupat highestriskforHUS and
(potentially
TTP), a similartrendwas seen; 43^0 (6/14)of the
SLT II-onlyisolateswerefromHUS-TTP patients
comparedwith13^0 (4/32) of isolateswithother
genotypes(RR, 3.4; CI, 0.9, 12.8).

Sinceage was associatedwithtoxingenotypeand
toxin genotypewas associated with systemicsebetweenthese
quelae,we examinedtherelationship
twovariablesusingthemethodof Thomas [16].We
controlledforone of thesetwovariableswhileexaminingtheotherwithsystemic
sequelae beingthe
forboth.Whencontrolling
outcomeof interest
for
toxingenotype,age was not a significant
riskfactorforsystemic
but
sequelae (P = .08,two-tailed),
whencontrolling
forage, a significant
association

SystemicSequelae in E. coli OI57:H7 Infections

betweentoxingenotype
and HUS and TTP waspresent (P = .01).
Antimicrobial
treatment
historywas knownin 78
of the 88 patientswhose isolateswereprobed.Of
thecases withknowntreatment
status,34 (44^0) receivedat leastone antimicrobial
while44 (56^0) did
withisolatesconnot;9 (53^0) of 17patientsinfected
tainingonlySLT II weretreatedcomparedwith25
(41Vo)of 61 patientsinfectedwiththe othergenotypes.In bothtreatedand untreatedpersons,those
infectedonlywithan SLT II organismhad a higher
riskof HUS and TTP. In thetreatedgroup,4 (44Vo)
of 9 SLT II-onlyisolateswerefromHUS-TTP patientscomparedwith1 (4^0) of 25 isolateswiththe
othergenotypes(RR, 11.1;CI, 1.3,440.8).In theuntreatedgroup,3 (38^0) of 8 SLT II-onlyisolateswere
fromHUS-TTP patientscomparedwith2 (6Vo)of
36 isolateswiththe othergenotypes(RR, 6.8; CI,
in0.9,58.9). Becausethenumberof cases receiving
dividualagentswas small,the data werenot analyzedby individualantimicrobialagent.
Discussion
associDuringthe12-mostudyperiod,a significant
ationbetweentoxingenotypeand clinicaloutcome
was found.E. coli 0157:H7 strainswiththeSLT II
genealoneweremorelikelythantheothergenotypes
to be isolatedfrompatientswithHUS or TTP. This
of age,whichis an imporfindingwas independent
tant risk factorfor these complications,and antimicrobial
use.Similartrendshavebeennotedelsewhere.As part of a studyof E. coli 0157 isolates
in GreatBritain,Scotlandet al. [17] notedthatalthoughmostisolatesin theirseriesproducedSLT
II alone,theseisolatesweremostcommonin cases
ofHUS. Tarretal. [15],inastudyofE. coliO\5TMl
isolatescollectedin thestateof Washington
during
1984-1987(including16patientsreported
here),also
notedthatorganismscontainingsolelySLT II genes
were more likelyto cause a diarrhealsyndrome
to HUS or TTP than wereorganisms
progressing
withothergenotypes(79^0 of genotypicSLT II organismswerefromHUS-TTP patients
comparedwith
47Voof organismswiththeothergenotypes).Howdidnotreachstatistiever,inthatseries,thefindings
cal significanceand theisolateswerenot collected
systematically.
Weobservedconsiderablestrainvariationamong
E. coli 0157:H7 clinicalisolatesdrawnfroma welldefinedgeographicarea. At least 13 different
plas-
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mid profilesand threeShiga-liketoxin genotype
combinationsweredetected.Our findings
probably
theactualstrainvariationin Washingunderestimate
forE. coli0157:H7 is nota stanton,sincescreening
dardprocedurein mostclinicallaboratoriesand the
isolatesreferred
werelikelyto be frommoreseverely
ill patients.Many laboratoriesscreenedforE. coli
0157:H7 onlyifthestoolspecimenappearedbloody
thatnon[11];someinvestigators
[3,4] havereported
in
diarrhea
E.
coli
0157:H7
infecbloody
sporadic
tionis unusual.Thus,ifclinicalmanifestations
are
failure
to
detect
with
or
mild
strain-related,
patients
illness
underestimate
strainvariation,
atypical
might
but as E. coli 0157:H7 appears to be rarein cases
of nonbloodydiarrhea,itis unlikely
thatmanycases
weremissed.
It is unclearwhyE. coli0157:H7 isolateswithonly
the SLT II gene should be morelikelyto produce
HUS and TTP. One possibleexplanationis thatisolates with only the SLT II gene produce greater
amountsof SLT II invivothando isolateswithboth
toxingenes.Anotherpossibility
isthatthisSLT genotypeacts as a markerforotheras yetunrecognized
virulencecharacteristics.
Evidence indicatesthat
Shiga-liketoxinplaysa crucialroleinthepathogenesis of boththeintestinaland extraintestinal
manifestationsof E. coli 0157:H7 infection[18], but
otherfactorsmayalso be important.Lastly,differencesinimmunologic
strain
responsetotheinfecting
a
role.
Ashkenazi
et
al.
have
demonmayplay
[19]
stratedantibodiesto SLT I, butnotSLT II, inpooled
commercialimmunoglobulin.
A briskanamnestic
to
response strainsproducingSLT I mayneutralize
of therelated,but
partor all ofthesystemic
toxicity
distinct,SLT II. All of these hypothesesremain
untiladequateanimalmodelsforhemorspeculative
rhagiccolitis with subsequentsystemicmicroangiopathyare developed,allowingthesehypotheses
to be testedin a controlledfashion.
The age-relateddifferences
notedbetweenE. coli
0157:H7 strainscould resultfromthesestrainsbecominghost-or food-adapted.If so, certainstrains
would preferentially
infectcertainsegmentsof the
An
population.
examplewould be a milk-specific
strainassociatedwithillnessin children.Sincefood
sourcesare difficult
to implicatein sporadiccases,
suchrelationships
couldnotbe assessedinourstudy.
The absence of genotypicSLT II-only isolates in
and maysupportthe
middle-aged
patientsis striking
that
strains
are
host
concept
adapted. No SLT IIisolates
were
in
detected
only
patientsbetweenthe
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agesof 17and 56 y,a groupinwhichisolateswith
theSLT I genewerefrequently
found.
Fiveisolateshadbecomenonviable
duringstor(fouradults
age.Theseisolateswerefrompatients
andonechild)withHC andwerenotgeographically
ortemporally
event
that
related.
Evenintheunlikely
all oftheseisolatespossessedonlytheSLT II gene,
and
therelationship
wefoundbetween
thisgenotype
storHUS-TTPwouldbe littlechanged.Although
ortoxingenoprofiles
agecouldhavealtered
plasmid
isolatesweresubjected
torepeated
several
plastype,
midanalysis
overa 1-yperiodwithnochangeinthe
thatstrainsfrompaAlso,it is doubtful
profiles.
tients
withHUS orTTP wouldlosetheSLT I gene
moreoftenthanisolatesfromotherpatients.
the
In summary,
it appearsthatin Washington
the
extrain0157:H7
and
between
E.
coli
relationship
is inpartdeterofinfection
testinal
manifestations
of theinfecting
strain.It
minedbycharacteristics
both
host
is likelythatbacterial
and
factors playa
cothesequelaeofhemorrhagic
roleindetermining
froma single
clinicaloutcomes
litis,sincemultiple
inthe
strain
oiE. coli0157:H7havebeenobserved
ourstudy
showsthatthe
outbreak
However,
setting.
needstobe adoftheseorganisms
diversity
genetic
of illnessin perthespectrum
dressedin assessing
Further
studies
sonswithE. coli0157:H7infections.
ifthisis also trueinareas
areneededto determine
otherthanWashington.
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